Drugs that contain Glycopyrronium Tosylate

1. Drug name - QBREXZA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10548875 JOURNEY Glycopyrrolate salts
Feb, 2033

(10 years from now)

CN105026369A JOURNEY Glycopyrronium Salt
Sep, 2018

(4 years ago)

EP2961734A1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

EP3473615B1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

EP2961734B1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

EP3473615A1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10052267 JOURNEY Topical glycopyrrolate formulations Oct, 2028

(6 years from now)

US8618160 JOURNEY Topical glycopyrrolate formulations Dec, 2029

(7 years from now)

US9744105 JOURNEY Topical glycopyrrolate formulations Jul, 2030

(7 years from now)

US10004717 JOURNEY Glycopyrrolate salts Feb, 2033

(10 years from now)

US10543192 JOURNEY Glycopyrrolate salts Feb, 2033

(10 years from now)

US8859610 JOURNEY Crystalline glycopyrrolate tosylate Feb, 2033

(10 years from now)

US9259414 JOURNEY Glycopyrrolate salts Feb, 2033

(10 years from now)

Treatment: Topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older

Dosage: CLOTH;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 2.4% BASE CLOTH;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.